Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.38B |
| 2 |
Microsoft
MSFT
|
+$2.02B |
| 3 |
Apple
AAPL
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$861M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.67B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$1.49B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$867M |
| 4 |
Tesla
TSLA
|
+$550M |
| 5 |
GE Aerospace
GE
|
+$483M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Financials | 6.62% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.85% |
| 5 | Communication Services | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Atlanticus Holdings
ATLC
$1.58B
| $242K | ﹤0.01% |
4,605
+3,960
| +614% | +$221K |
|
|
ISBA
3802
Isabella Bank
ISBA
$305M
| $242K | ﹤0.01% |
5,290
+3,037
| +135% | +$147K |
|
3803
Ecovyst
ECVT
$1.35B
| $240K | ﹤0.01% |
18,699
+6,102
| +48% | +$68.9K |
|
3804
Babcock & Wilcox
BW
$1.31B
| $240K | ﹤0.01% |
16,323
+892
| +6% | +$9.38K |
|
3805
Monte Rosa Therapeutics
GLUE
$1.86B
| $240K | ﹤0.01% |
14,575
+3,889
| +36% | +$74.4K |
|
3806
Red River Bancshares
RRBI
$672M
| $239K | ﹤0.01% |
2,642
+2,107
| +394% | +$178K |
|
3807
Inter&Co
INTR
$2.47B
| $239K | ﹤0.01% |
+30,000
| New | +$260K |
|
3808
Aemetis
AMTX
$104M
| $239K | ﹤0.01% |
+74,842
| New | +$136K |
|
|
NFBK
3809
DELISTED
Northfield Bancorp
NFBK
| $237K | ﹤0.01% |
17,532
-4,068
| -19% | -$52.4K |
|
|
DCH
3810
PUT
Dauch Corp
DCH
$1.33B
| $237K | ﹤0.01% |
+40,000
| New | +$278K |
|
3811
MannKind Corp
MNKD
$1.21B
| $236K | ﹤0.01% |
96,504
+23,159
| +32% | +$103K |
|
3812
Cooper-Standard Automotive
CPS
$526M
| $236K | ﹤0.01% |
8,476
+8,092
| +2,107% | +$271K |
|
3813
Sonos
SONO
$2B
| $236K | ﹤0.01% |
17,594
-7,168
| -29% | -$108K |
|
3814
Altimmune
ALT
$581M
| $235K | ﹤0.01% |
76,327
+48,003
| +169% | +$204K |
|
3815
VanEck Biotech ETF
BBH
$409M
| $234K | ﹤0.01% |
+1,246
| New | +$240K |
|
3816
Braze
BRZE
$2.83B
| $234K | ﹤0.01% |
9,919
-851
| -8% | -$18.4K |
|
|
BIOA
3817
BioAge Labs
BIOA
$974M
| $234K | ﹤0.01% |
13,384
+11,846
| +770% | +$228K |
|
3818
XPEL
XPEL
$1.21B
| $234K | ﹤0.01% |
5,279
-141
| -3% | -$6.74K |
|
3819
Adtran
ADTN
$730M
| $232K | ﹤0.01% |
18,427
+4,803
| +35% | +$48.7K |
|
3820
ProShares Russell 2000 Dividend Growers ETF
SMDV
$709M
| $232K | ﹤0.01% |
3,367
+70
| +2% | +$4.92K |
|
3821
Aurinia Pharmaceuticals
AUPH
$1.92B
| $231K | ﹤0.01% |
15,604
+7,972
| +104% | +$117K |
|
3822
iShares International Equity Factor ETF
INTF
$3.57B
| $230K | ﹤0.01% |
5,896
-1,209
| -17% | -$47.9K |
|
3823
Tyra Biosciences
TYRA
$1.84B
| $229K | ﹤0.01% |
5,991
+2,174
| +57% | +$70.4K |
|
3824
Avantis Emerging Markets Equity ETF
AVEM
$24.9B
| $229K | ﹤0.01% |
+2,845
| New | +$236K |
|
3825
Cadeler
CDLR
$2.08B
| $229K | ﹤0.01% |
9,734
+3,944
| +68% | +$93.1K |
|
Similar funds
Citigroup's Q1 2026 Portfolio in Review
As of Q1 2026, Citigroup held 6,546 positions worth $235B, up 3.5% from $227B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citigroup deployed $16.9B of net new capital in Q1 2026, opening 553 new positions and adding to 2,742 existing holdings. Its largest new stake was Oracle Corp Preferred Stock Series D: 1,846,042 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.67B trimmed.
- Citigroup's largest Q1 2026 buy was Oracle Corp Preferred Stock Series D: 1,846,042 shares worth $83.1M.
- Citigroup added most to NVIDIA in Q1 2026, an estimated $2.38B increase.
- Citigroup's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.67B.
- Citigroup fully exited CyberArk in Q1 2026, selling an estimated $241M.
- Citigroup's ten largest holdings make up 19% of its $235B portfolio in Q1 2026.
- Citigroup opened 553 new positions and closed 630 in Q1 2026.
- Citigroup's portfolio value rose 3.5% quarter-over-quarter to $235B.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.